Research has shown exenatide to be safe to use with thiazolidine-diones (TZDs). Now researchers from the University of California at San Francisco in San Francisco, California; Cambridge Memorial Hospital in Cambridge, Ontario, Canada; Pharmanet/i3, Inc. in Ann Arbor, Michigan; Consultmed SRL in Iasi, Romania; and Eli Lilly and Company in Indianapolis, Indiana, say the extended-release formula-tion is also safe, both in exenatide-naïve patients and those switching from twice-daily treatment.
More Headlines